NDC 70436-123 – Gadoterate meglumine
Gadoterate Meglumine 376.9 mg/mL · Injection · Intravenous
Product NDC70436-123
Product details
- Brand name
- Gadoterate meglumine
- Generic name
- Gadoterate meglumine
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA218073
- Marketed since
- June 28, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Gadolinium-based Contrast Agent
Active ingredients
- Gadoterate Meglumine 376.9 mg/mL
Uses, dosage, side effects and warnings for Gadoterate Meglumine →
Package NDC codes (6)
| Package NDC | Description | Since |
|---|---|---|
| 70436-123-31 | 10 VIAL in 1 CARTON (70436-123-31) / 5 mL in 1 VIAL | Jun 28, 2024 |
| 70436-123-33 | 10 VIAL in 1 CARTON (70436-123-33) / 10 mL in 1 VIAL | Jun 28, 2024 |
| 70436-123-34 | 10 VIAL in 1 CARTON (70436-123-34) / 15 mL in 1 VIAL | Jun 28, 2024 |
| 70436-123-35 | 10 VIAL in 1 CARTON (70436-123-35) / 20 mL in 1 VIAL | Jun 28, 2024 |
| 70436-123-56 | 6 VIAL in 1 CARTON (70436-123-56) / 100 mL in 1 VIAL (70436-123-40) | Aug 1, 2024 |
| 70436-123-80 | 1 VIAL in 1 CARTON (70436-123-80) / 100 mL in 1 VIAL (70436-123-40) | Jun 28, 2024 |
Other Gadoterate Meglumine products
- 65219-080 Gadoterate Meglumine 376.9 mg/mL · Injection · Fresenius Kabi USA, LLC
- 65219-082 Gadoterate Meglumine 376.9 mg/mL · Injection · Fresenius Kabi USA, LLC
- 65219-084 Gadoterate Meglumine 376.9 mg/mL · Injection · Fresenius Kabi USA, LLC
- 65219-086 Gadoterate Meglumine 376.9 mg/mL · Injection · Fresenius Kabi USA, LLC
- 65219-088 Gadoterate Meglumine 376.9 mg/mL · Injection · Fresenius Kabi USA, LLC